BioXcel Therapeutics, Inc. Common Stock (NASDAQ: BTAI) last traded at $0.0740. The quote above updates while this page is open; the figures below are drawn from BioXcel Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
BioXcel Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker BTAI. Its market capitalisation is $2.32 million.
Valuation measures for BioXcel Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.32M |
|---|---|
| Enterprise value | $133.73M |
| Price / sales | 3.12 |
Trailing-twelve-month figures tagged in BioXcel Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $742.0K |
|---|---|
| Net income (TTM) |
| -$70.86M |
| EPS (TTM) | -$2.81 |
|---|
| Gross margin | 53.10% |
|---|
| Operating margin | -6054.72% |
|---|
| Cash | $12.84M |
|---|
Range and volume for BTAI over the past 52 weeks.
| 52-week high | $0.197 |
|---|---|
| 52-week low | $0.0190 |
| Volume | 47.48M |
| Average volume | 819.2K |
| Previous close | $0.00 |
Invest a chosen dollar amount in BioXcel Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BTAI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.